02192 MEDLIVE
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 21.03X | Oper Margin | 61.1% |
|---|---|---|---|
| LT Debt/Equity | 0.2% | Net Margin | 56.4% |
| Total Debt/Equity | 0.5% | Return on Equity | 6.6% |
| Price/Book | 2.04X | Return on Assets | 6.2% |
| (HKD 14.180) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 335.16 | 267.06 | 131.54 | 49.68 | 101.11 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +25.5 | +103.0 | +164.8 | -50.9 | +189.3 |
| Earnings Per Share (HKD) | 0.46 | 0.37 | 0.184 | 0.081 | 0.189 |
| Earnings Per Share Growth (%) | +24.3 | +100.9 | +128.4 | -57.4 | +189.4 |
| Dividend Per Share (HKD) | 0.280 | 0.254 | 0.075 | 0.021 | No dividend |
| P/E* (X) | 30.85 | 38.33 | 77.02 | 175.93 | 75.03 |
| Yield (%) | 1.97 | 1.79 | 0.53 | 0.15 | N/A |
| Dividend Share (%) | 60.91 | 68.67 | 40.58 | 25.93 | N/A |
| Book NAV (HKD) | 6.964 | 6.970 | 6.879 | 6.772 | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 558.455 | 412.004 | +35.5 | 314.054 |
| Operating Result | 340.474 | 253.127 | +34.5 | 135.025 |
| Associates | 0 | 0.005 | -100.0 | 0.012 |
| Profit Before Taxation | 340.474 | 253.132 | +34.5 | 135.037 |
| Taxation | 10.173 | 1.372 | +641.5 | 8.616 |
| Profit /( Loss) After Taxation | 330.301 | 251.76 | +31.2 | 126.421 |
| Minority Interests | 15.155 | 9.459 | +60.2 | 9.1 |
| Net Profit | 315.146 | 242.301 | +30.1 | 117.321 |
| Earnings Per Share () | 0.4597 | 0.3699 | +24.3 | 0.1841 |
| Dividend Per Share () | 0.2800 | 0.2540 | +10.2 | 0.0747 |
| Announcement Date | 2025-03-24 | 2024-03-25 | NA | 2023-03-23 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
